MoonLake Immunotherapeutics (MLTX) — Financial Flexibility Index
MoonLake Immunotherapeutics (MLTX) has a Financial Flexibility Index of -0.49x as of December 2025. Free cash flow of $-58.79 Million (operating CF $-58.79 Million minus capex $0.00) represents 0% of total liabilities ($119.95 Million). Check how strategically is MoonLake Immunotherapeutics's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MoonLake Immunotherapeutics Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for MoonLake Immunotherapeutics across 6 annual periods. See MLTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MoonLake Immunotherapeutics (2020–2025)
Year-by-year free cash flow to debt coverage for MoonLake Immunotherapeutics. For the full company profile including market capitalisation, see MLTX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.63x | $-195.97 Million | $-196.01 Million | $119.95 Million | ▲ +65.5% |
| 2024 | -4.73x | $-116.07 Million | $-116.59 Million | $24.54 Million | ▼ -45.2% |
| 2023 | -3.26x | $-42.49 Million | $-42.78 Million | $13.05 Million | ▲ +52.9% |
| 2022 | -6.92x | $-55.88 Million | $-55.89 Million | $8.08 Million | ▼ -320.1% |
| 2021 | -1.65x | $-35.12 Million | $-35.18 Million | $21.33 Million | ▼ -2058.2% |
| 2020 | -0.08x | $-316.69K | $-316.69K | $4.15 Million | — |